Literature DB >> 20526544

Prevalence of rosacea in an Estonian working population using a standard classification.

Kristi Abram1, Helgi Silm, Marje Oona.   

Abstract

Data about the prevalence of rosacea are scarce. The aim of this study was to evaluate the prevalence rate of rosacea according to the American National Rosacea Society Expert Committee (NRSEC) classification. A cross-sectional study of 348 subjects randomly selected from a working population >or= 30 years of age was performed. All subjects completed a questionnaire. Skin status was examined according to NRSEC criteria. Of the 348 subjects, 78 (22%) had one or more primary features of rosacea. The most common features were erythema (21%) and telangiectasia (18%). Of the subjects with rosacea, 78% had erythematotelangiectatic rosacea and 22% had papulopustular rosacea. Fifteen percent of the study subjects had experienced frequent episodes of flushing without permanent features of rosacea. No significant gender-related differences were found between study groups. In conclusion, according to the NRSEC, rosacea is a more common skin condition over the age of 30 years than previously thought.

Entities:  

Mesh:

Year:  2010        PMID: 20526544     DOI: 10.2340/00015555-0856

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  15 in total

Review 1.  Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.

Authors:  Martin Steinhoff; Jörg Buddenkotte; Jerome Aubert; Mathias Sulk; Pawel Novak; Verena D Schwab; Christian Mess; Ferda Cevikbas; Michel Rivier; Isabelle Carlavan; Sophie Déret; Carine Rosignoli; Dieter Metze; Thomas A Luger; Johannes J Voegel
Journal:  J Investig Dermatol Symp Proc       Date:  2011-12

2.  Minocycline Extended-Release Comparison with Doxycycline for the Treatment of Rosacea: A Randomized, Head-to-Head, Clinical Trial.

Authors:  Athanasios Tsianakas; Thomas Pieber; Hilary Baldwin; Franz Feichtner; Shanavas Alikunju; Anirudh Gautam; Srinivas Shenoy; Preeti Singh; Srinivas Sidgiddi
Journal:  J Clin Aesthet Dermatol       Date:  2021-12

3.  Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study.

Authors:  Todd Williamson; Wendy Y Cheng; Nora McCormick; Francis Vekeman
Journal:  Am Health Drug Benefits       Date:  2018-04

4.  Perceptions on the Psychological Impact of Facial Erythema Associated with Rosacea: Results of International Survey.

Authors:  Thomas Dirschka; Giuseppe Micali; Linda Papadopoulos; Jerry Tan; Alison Layton; Simon Moore
Journal:  Dermatol Ther (Heidelb)       Date:  2015-05-29

Review 5.  Recent advances in the understanding and management of rosacea.

Authors:  Uwe Wollina
Journal:  F1000Prime Rep       Date:  2014-07-08

6.  Update on the management of rosacea.

Authors:  Allison P Weinkle; Vladyslava Doktor; Jason Emer
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-04-07

7.  High prevalence of skin diseases and need for treatment in a middle-aged population. A Northern Finland Birth Cohort 1966 study.

Authors:  Suvi-Päivikki Sinikumpu; Laura Huilaja; Jari Jokelainen; Markku Koiranen; Juha Auvinen; Päivi M Hägg; Erika Wikström; Markku Timonen; Kaisa Tasanen
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

Review 8.  Orphan diseases of the nose and paranasal sinuses: Pathogenesis - clinic - therapy.

Authors:  Martin Laudien
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

Review 9.  The role of brimonidine tartrate gel in the treatment of rosacea.

Authors:  J Mark Jackson; Melissa Knuckles; John Paul Minni; Sandra Marchese Johnson; Kevin Tate Belasco
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-10-23

10.  Development and Evaluation of a Rosacea Screening Instrument (Rosascreen).

Authors:  Jerry Tan; James Leyden; Bernard Cribier; Fabien Audibert; Nabil Kerrouche; Mats Berg
Journal:  J Cutan Med Surg       Date:  2016-02-01       Impact factor: 2.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.